Patients with advanced-stage melanoma who received immunotherapy both before and after surgery had longer event-free survival than patients who received immunotherapy only after surgery, according to a recent clinical trial published in the New England Journal of Medicine.
Combining a new hormone therapy drug with chemotherapy and another hormone therapy increased overall survival in patients with high-volume and both high-risk and low-risk metastatic hormone-sensitive prostate cancer, according to a post hoc analysis published in the Journal of Clinical Oncology.
Northwestern Medicine scientists have identified a new compound which could inform future HIV cure strategies, according to research published in Science Advances.
Northwestern Medicine scientists have developed a new tool to predict the risk of venous thromboembolism in patients with adult-type diffuse gliomas.
Northwestern Medicine scientists have uncovered a mechanism by which exercise activates metabolic benefits in the body, according to a new study published in Cell Metabolism.
People with sickle cell disease who receive nonmyeloablative stem cell transplants are at greater risk for developing new tumors, according to a new study published in the Journal of Clinical Oncology.
Northwestern Medicine scientists have identified a gene that plays a role in cellular responses to molecular stressors, such as DNA damage and nutrient scarcity.
Oral vitamin D supplements reduced skin inflammation and increased immunoprotection in patients with chemical skin injuries, according to findings from a recent Northwestern Medicine clinical trial.
Investigators have discovered that a specific complex drives cell proliferation in mutated myeloproliferative neoplasms, suggesting this complex could serve as an ideal therapeutic target, according to a recent Northwestern medicine study.
A new way to significantly increase the potency of almost any vaccine has been developed by Northwestern scientists.